Allogeneic multipotent mesenchymal bone marrow stromal cells induce a rejection reaction

A. S. Grigoryan

Genes & Cells ›› 2006, Vol. 1 ›› Issue (4) : 13 -14.

News of cellular technologies Cell biology

brief-report

Allogeneic multipotent mesenchymal bone marrow stromal cells induce a rejection reaction

A. S. Grigoryan

Author information +

History +

Abstract

Cite this article

Download citation ▾

A. S. Grigoryan. Allogeneic multipotent mesenchymal bone marrow stromal cells induce a rejection reaction. Genes & Cells, 2006, 1(4): 13-14 DOI:

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Сергеев В.С. Иммунологические свойства мультипотентных мезенхимных стромальных клеток. Клеточная трансплантология и тканевая инженерия 2005; 2: 39- 2.

[2]	Bartholomew A., Sturgeon C., Siatskas M. et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 2002; 30: 42-8.

[3]	Di Nicola M., Carlo-Stella C., Magni M. et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-43.

[4]	Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogenic immune cell responses. Blood 2005; 105: 1815-22.

[5]	Djouad F., Plence P., Bony C. et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102: 3837-44.

[6]

Almeida-Porada G., Porada C.D., Tran N., Zanjani E.D. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 2000; 95: 3620-7.

[7]	Noort W.A., Kruisselbrink A.B., in™t Anker P.S. et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp. Hematol. 2002; 30: 870-8.

[8]	Lazarus H.M., Koc O.N., Devine S.M. et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood Marrow Transplant. 2005; 11(5): 389-98.

[9]	Koc O.N., Gerson S.L., Cooper B.W. et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 2000; 18: 307-16.

[10]	Horwitz E.M., Prockop D.J., Fitzpatrick L.A. et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 1999; 5: 309-13.